Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease
Open accessAbstract
Sphingolipids, which function as plasma membrane lipids and signaling molecules, are highly enriched in neuronal and myelin membranes in the nervous system. They are degraded in lysosomes by a defined sequence of enzymatic steps. In the related group of disorders, the sphingolipidoses, mutations in the genes that encode the individual degradative enzymes cause lysosomal accumulation of sphingolipids and often result in severe neurodegenerative disease. Here we review the information indicating that microglia, which actively clear sphingolipid-rich membranes in the brain during development and homeostasis, are directly affected by these mutations and promote neurodegeneration in the sphingolipidoses. We also identify parallels between the sphingolipidoses and more common forms of neurodegeneration, which both exhibit evidence of defective sphingolipid clearance in the nervous system.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lysosomes require a highly acidic pH (~4.5-4.7) achieved through import of protons from the cytosol into the organellar lumen.
“To function effectively, lysosomes require a highly acidic pH (~4.5 – 4.7) that is achieved through import of protons from the cytosol into the organellar lumen.4”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [4]
The Introduction describes sphingolipid degradation in lysosomes and names acid-dependent enzymes, but does not give a lysosomal pH or explain how lysosomes are acidified. Searches of our copy for pH 4.5–4.7, proton import, and lysosomal acidification found no passage addressing those parts of the claim. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,331 · see citing works
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · see citing works
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894 · see citing works
Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135 · see citing works
Microglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935 · cited 1× · see citing works
“Importantly, the majority of risk genes for Alzheimer’s disease are expressed in microglia, with many being microglia-specific [118].”
BackgroundMasters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853 · see citing works
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · see citing works
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455 · see citing works
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0566-1 · Cited by 1,384 · see citing works
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · see citing works
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112 · see citing works
Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052 · see citing works
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911 · see citing works
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · see citing works
Lloyd‐Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 832 · see citing works
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 781 · see citing works
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., Llapashtica, C., Wang, J., Kim, D. J., Xia, D., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.007 · Cited by 745 · see citing works
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718 · see citing works
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701 · see citing works
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Platt, F. M., Boland, B., & van der Spoel, A. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208152 · Cited by 689 · see citing works
Kwon, H. J., Abi-Mosleh, L., Wang, M. L., Deisenhofer, J., Goldstein, J. L., Brown, M. S., & Infante, R. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.049 · Cited by 656 · see citing works
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618 · see citing works
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works
Age-related myelin degradation burdens the clearance function of microglia during aging
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., Edinger, A. L., Jung, S., Rossner, M. J., & Simons, M. (2016) · Nature Neuroscience · doi:10.1038/nn.4325 · Cited by 604 · see citing works
Lysosomal disorders: From storage to cellular damage
Ballabio, A., & Gieselmann, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.001 · Cited by 571 · see citing works
TREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · see citing works
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Horinouchi, K., Erlich, S. S., Perl, D. P., Ferlinz, K., Bisgaier, C. L., Sandhoff, K., Desnick, R. J., Stewart, C. L., & Schuchman, E. H. (1995) · Nature Genetics · doi:10.1038/ng0795-288 · Cited by 471 · see citing works
Neuropathology provides clues to the pathophysiology of Gaucher disease
Wong, K., Sidransky, E., Verma, A. M., Mixon, T., Sandberg, G. D., Wakefield, L. K., Morrison, A. L., Lwin, A., Colegial, C. H., Allman, J. M., et al. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.011 · Cited by 453 · see citing works
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain · doi:10.1093/brain/awx285 · Cited by 433 · see citing works
Generalized Gangliosidosis: Beta-Galactosidase Deficiency
Okada, S., & O’Brien, J. S. (1968) · Science · doi:10.1126/science.160.3831.1002 · Cited by 428 · see citing works
Wada, R., Tifft, C. J., & Proia, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10954 · Cited by 403 · see citing works
Self-citationJeyakumar, M. (2003) · Brain · doi:10.1093/brain/awg089 · Cited by 348 · see citing works
Types A and B Niemann-Pick disease
Schuchman, E. H., & Desnick, R. J. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.008 · Cited by 343 · see citing works
Sphingolipid lysosomal storage disorders
Platt, F. M. (2014) · Nature · doi:10.1038/nature13476 · Cited by 320 · see citing works
Novel Hexb-based tools for studying microglia in the CNS
Masuda, T., Amann, L., Sankowski, R., Staszewski, O., Lenz, M., d´Errico, P., Snaidero, N., Costa Jordão, M. J., Böttcher, C., Kierdorf, K., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0707-4 · Cited by 317 · see citing works
Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology
Sierksma, A., Lu, A., Mancuso, R., Fattorelli, N., Thrupp, N., Salta, E., Zoco, J., Blum, D., Buée, L., De Strooper, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910606 · Cited by 291 · see citing works
Microglia and the brain: Complementary partners in development and disease
Hammond, T. R., Robinton, D., & Stevens, B. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060509 · Cited by 288 · see citing works
Suzuki, K. (1998) · Neurochemical Research · doi:10.1023/a:1022436928925 · Cited by 282 · see citing works
Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease
Purpura, D. P., & Suzuki, K. (1976) · Brain Research · doi:10.1016/0006-8993(76)90245-6 · Cited by 277 · see citing works
Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders
Conzelmann, E., & Sandhoff, K. (2007) · Developmental Neuroscience · doi:10.1159/000112332 · Cited by 272 · see citing works
MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
Sidransky, E., Samaddar, T., & Tayebi, N. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b28601 · Cited by 265 · see citing works
Biffi, A., Palma, M. D., Quattrini, A., Carro, U. D., Amadio, S., Visigalli, I., Sessa, M., Fasano, S., Brambilla, R., Marchesini, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19205 · Cited by 261 · see citing works
How synaptic pruning shapes neural wiring during development and, possibly, in disease
Sakai, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010281117 · Cited by 221 · see citing works
Krabbe Disease: Genetic Aspects and Progress toward Therapy
Wenger, D. A., Rafi, M. A., Luzi, P., Datto, J., & Costantino‐Ceccarini, E. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.2990 · Cited by 215 · see citing works
Ganglioside/glycosphingolipid turnover: New concepts
Tettamanti, G. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000033627.02765.cc · Cited by 212 · see citing works
Metachromatic leukodystrophy: Disease spectrum and approaches for treatment
van Rappard, D. F., Boelens, J. J., & Wolf, N. I. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.10.001 · Cited by 211 · see citing works
Otterbach, B., & Stoffel, W. (1995) · Cell · doi:10.1016/s0092-8674(05)80010-8 · Cited by 210 · see citing works
Lysosomal Lipid Storage DiseasesPreprint
Schulze, H., & Sandhoff, K. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004804 · Cited by 198 · see citing works
Murine models of acute neuronopathic Gaucher disease
Enquist, I. B., Bianco, C. L., Ooka, A., Nilsson, E., Månsson, J., Ehinger, M., Richter, J., Brady, R. O., Kirik, D., & Karlsson, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708086104 · Cited by 197 · see citing works
The Role and Metabolism of Sulfatide in the Nervous System
Eckhardt, M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8022-3 · Cited by 193 · see citing works
Mohri, I., Taniike, M., Taniguchi, H., Kanekiyo, T., Aritake, K., Inui, T., Fukumoto, N., Eguchi, N., Kushi, A., Sasai, H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4531-05.2006 · Cited by 185 · see citing works
A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM*
Austin, J. H., Balasubramanian, A. S., Pattabiraman, T. N., Saraswathi, S., Basu, D., & Bachhawat, B. K. (1963) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1963.tb11905.x · Cited by 185 · see citing works
Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice
Wu, Y., & Proia, R. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400625101 · Cited by 183 · see citing works
Self-citationVanier, M. T. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00041-1 · Cited by 183 · see citing works
Vanier, M. T., Wenger, D. A., Comly, M. E., Rousson, R., Brady, R. O., & Pentchev, P. G. (1988) · Clinical Genetics · doi:10.1111/j.1399-0004.1988.tb03460.x · Cited by 180 · see citing works
Hahn, C. N., Martin, M. D. P., Schroder, M., Vanier, M. T., Suzuki, K., Hara, Y., Suzuki, K., & d’Azzo, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.205 · Cited by 173 · see citing works
Sphingolipids: Critical players in Alzheimer’s disease
van Echten‐Deckert, G., & Walter, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.07.001 · Cited by 172 · see citing works
Li, X., Saha, P., Li, J., Blobel, G., & Pfeffer, S. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611956113 · Cited by 170 · see citing works
Huebecker, M., Moloney, E. B., van der Spoel, A. C., Priestman, D. A., Ole Isacson, A., Hallett, P. J., & Platt, F. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0339-z · Cited by 165 · see citing works
Myerowitz, R., Lawson, D., Mizukami, H., Mi, Y.-D., Tifft, C., & Proia, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1343 · Cited by 161 · see citing works
Self-citationIntracellular Cholesterol Trafficking and Impact in Neurodegeneration
Arenas, F., García‐Ruiz, C., & Fernández-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 161 · see citing works
Vitner, E. B., Farfel‐Becker, T., Eilam, R., Biton, I. E., & Futerman, A. H. (2012) · Brain · doi:10.1093/brain/aws095 · Cited by 159 · see citing works
Norflus, F., Tifft, C. J., McDonald, M. P., Goldstein, G., Crawley, J. N., Hoffmann, A., Sandhoff, K., Suzuki, K., & Proia, R. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2127 · Cited by 157 · see citing works
Self-citationLysosomal Glycosphingolipid Storage Diseases
Breiden, B., & Sandhoff, K. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111518 · Cited by 146 · see citing works
Secretory sphingomyelinase in health and disease
Kornhuber, J., Rhein, C., Müller, C. P., & Mühle, C. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0109 · Cited by 145 · see citing works
Ferraz, M. J., Marques, A., Appelman, M. D., Verhoek, M., Strijland, A., Mirzaian, M., Scheij, S., Ouairy, C. M. J., Lahav, D., Wisse, P., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12104 · Cited by 141 · see citing works
Trifunctional lipid probes for comprehensive studies of single lipid species in living cells
Höglinger, D., Nadler, A., Haberkant, P., Kirkpatrick, J. M., Schifferer, M., Stein, F., Hauke, S., Porter, F. D., & Schultz, C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611096114 · Cited by 140 · see citing works
Farber disease: clinical presentation, pathogenesis and a new approach to treatment
Ehlert, K., Frosch, M., Fehse, N., Zander, A. R., Roth, J., & Vormoor, J. H. (2007) · Pediatric Rheumatology · doi:10.1186/1546-0096-5-15 · Cited by 139 · see citing works
Fischer, G., & Jatzkewitz, H. (1975) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1975.356.1.605 · Cited by 137 · see citing works
Jeon, S., Yoon, H. J., Park, S., Kim, I.-H., & Park, E. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8077 · Cited by 134 · see citing works
Keatinge, M., Bui, H. H., Menke, A. L., Chen, Y., Sokòl, A. M., Bai, Q., Ellett, F. E., Costa, M. D., Burke, D. G., Gegg, M. E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv369 · Cited by 130 · see citing works
Neuroinflammatory paradigms in lysosomal storage diseases
Bosch, M. E., & Kielian, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00417 · Cited by 126 · see citing works
Farfel‐Becker, T., Vitner, E. B., Pressey, S. N., Eilam, R., Cooper, J. D., & Futerman, A. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr019 · Cited by 119 · see citing works
Emerging concepts of ganglioside metabolism
Sandhoff, R., & Sandhoff, K. (2018) · FEBS Letters · doi:10.1002/1873-3468.13114 · Cited by 115 · see citing works
Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia
Colombo, A. V., Dinkel, L., Müller, S. A., Monasor, L. S., Schifferer, M., Cantuti‐Castelvetri, L., König, J., Vidatic, L., Brémovà-Ertl, T., Lieberman, A. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21428-5 · Cited by 111 · see citing works
Systemic ceramide accumulation leads to severe and varied pathological consequences
Alayoubi, A. M., Wang, J. C. M., Au, B. C. Y., Carpentier, S., Garcia, V., Dworski, S., Ghamrasni, S. E., Kirouac, K. N., Exertier, M. J., Xiong, Z. J., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202301 · Cited by 107 · see citing works
Keilani, S., Lun, Y., Stevens, A. C., Williams, H. N., Sjoberg, E. R., Khanna, R., Valenzano, K. J., Checler, F., Buxbaum, J. D., Yanagisawa, K., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4860-11.2012 · Cited by 98 · see citing works
NPC1/NPC2 function as a tag team duo to mobilize cholesterol
Subramanian, K., & Balch, W. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808256105 · Cited by 96 · see citing works
Wu, Y., Mizugishi, K., Bektas, M., Sandhoff, R., & Proia, R. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn126 · Cited by 96 · see citing works
Self-citationGabandé‐Rodríguez, E., Pérez‐Cañamás, A., Soto‐Huelin, B., Mitroi, D. N., Sánchez‐Redondo, S., Martínez-Sáez, E. A., Venero, C., Peinado, H., & Ledesma, M. D. (2018) · The EMBO Journal · doi:10.15252/embj.201899553 · Cited by 95 · see citing works
Sarna, J. R., Miranda, S. R. P., Schuchman, E. H., & Hawkes, R. B. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01564.x · Cited by 95 · see citing works
Bergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94 · see citing works
Degradation of Membrane-bound Ganglioside GM1
Wilkening, G., Linke, T. A., Uhlhorn-Dierks, G., & Sandhoff, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006568200 · Cited by 93 · see citing works
Human and mouse neuroinflammation markers in Niemann‐Pick disease, type C1
Cologna, S. M., Cluzeau, C. V. M., Yanjanin, N. M., Blank, P. S., Dail, M. K., Siebel, S., Toth, C. L., Wassif, C. A., Lieberman, A. P., & Porter, F. D. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9610-6 · Cited by 88 · see citing works
Microglia activation in Niemann–Pick disease, type C1 is amendable to therapeutic intervention
Cougnoux, A., Drummond, R. A., Collar, A. L., Iben, J., Salman, A., Westgarth, H. J., Wassif, C. A., Cawley, N. X., Farhat, N. Y., Ozato, K., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy112 · Cited by 85 · see citing works
Sano, R., Tessitore, A., Ingrassia, A. M. T., & d’Azzo, A. (2005) · Blood · doi:10.1182/blood-2005-03-1189 · Cited by 84 · see citing works
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
Beerepoot, S., Nierkens, S., Boelens, J. J., Lindemans, C. A., Bugiani, M., & Wolf, N. I. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1220-4 · Cited by 81 · see citing works
Niemann-Pick type C disease: The atypical sphingolipidosis
Newton, J. C., Milstien, S., & Spiegel, S. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.08.001 · Cited by 80 · see citing works
Cross-talk of membrane lipids and Alzheimer-related proteins
Walter, J., & van Echten‐Deckert, G. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-34 · Cited by 77 · see citing works
Moser, H. W., Prensky, A. L., Wolfe, H. J., & Rosman, N. P. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90202-2 · Cited by 76 · see citing works
Saposin C Is Required for Normal Resistance of Acid β-Glucosidase to Proteolytic Degradation
Sun, Y., Qi, X., & Grabowski, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302752200 · Cited by 73 · see citing works
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
Lee, J. S., Kanai, K., Suzuki, M., Kim, W. S., Yoo, H. S., Fu, Y., Kim, D.-K., Jung, B. C., Choi, M.-S., Oh, K. W., et al. (2019) · Brain · doi:10.1093/brain/awz205 · Cited by 71 · see citing works
Bascou, N. A., DeRenzo, A., Poe, M. D., & Escolar, M. L. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0872-9 · Cited by 68 · see citing works
The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure
Hill, C. H., Cook, G. M., Spratley, S. J., Fawke, S., Graham, S. C., & Deane, J. E. (2018) · Nature Communications · doi:10.1038/s41467-017-02361-y · Cited by 62 · see citing works
Weinstock, N. I., Shin, D., Dhimal, N., Hong, X., Irons, E. E., Silvestri, N. J., Reed, C. B., Nguyen, D. A., Sampson, O., Cheng, Y., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.03.031 · Cited by 60 · see citing works
Kyrkanides, S., Miller, A. W., Miller, J. H., Tallents, R. H., Brouxhon, S. M., Olschowka, M. E., O’Banion, M. K., & Olschowka, J. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.024 · Cited by 59 · see citing works
Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease
Potter, G. B., Santos, M. B., Davisson, M. T., Rowitch, D. H., Marks, D. L., Bongarzone, E. R., & Petryniak, M. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt190 · Cited by 59 · see citing works
Macrophages Counteract Demyelination in a Mouse Model of Globoid Cell Leukodystrophy
Kondo, Y., Adams, J. M., Vanier, M. T., & Duncan, I. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6344-10.2011 · Cited by 58 · see citing works
Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice
Abo-ouf, H., Hooper, A. W. M., White, E. J., van Rensburg, H. J. J., Trigatti, B. L., & Igdoura, S. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt250 · Cited by 56 · see citing works
Macauley, S. L., Sidman, R. L., Schuchman, E. H., Taksir, T. V., & Stewart, G. R. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.026 · Cited by 55 · see citing works
Upregulation of Proinflammatory Cytokines in the Fetal Brain of the Gaucher Mouse
Hong, Y. B., Kim, E. Y., & Jung, S. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.4.733 · Cited by 53 · see citing works
Innate Immune Activation in the Pathogenesis of a Murine Model of Globoid Cell Leukodystrophy
Snook, E. R., Fisher‐Perkins, J. M., Sansing, H. A., Lee, K. M., Alvarez, X. A., MacLean, A. G., Peterson, K. E., Lackner, A. A., & Bunnell, B. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.011 · Cited by 50 · see citing works
Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities
Sikora, J., Dworski, S., Jones, E. E., Kamani, M. A., Micsenyi, M. C., Sawada, T., Faouder, P. L., Bertrand‐Michel, J., Dupuy, A., Dunn, C. K., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.005 · Cited by 50 · see citing works
Stein, A., Stroobants, S., Gieselmann, V., D’Hooge, R., & Matzner, U. (2015) · Molecular Therapy · doi:10.1038/mt.2015.69 · Cited by 50 · see citing works
Borda, J. T., Alvarez, X. A., Mohan, M., Ratterree, M. S., Phillippi‐Falkenstein, K. M., Lackner, A. A., & Bunnell, B. A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070404 · Cited by 50 · see citing works
Neuronal Forms of Gaucher Disease
Vitner, E. B., & Futerman, A. H. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_20 · Cited by 48 · see citing works
Immune Response in Leukodystrophies
Eichler, F., & van Haren, K. P. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.06.011 · Cited by 47 · see citing works
Kuil, L. E., Martí, A. L., Mascaro, A. C., van den Bosch, J. C., van den Berg, P., van der Linde, H. C., Schoonderwoerd, K. C., Ruijter, G. J. G., & van Ham, T. J. (2019) · Glia · doi:10.1002/glia.23641 · Cited by 44 · see citing works
Pérez‐Cañamás, A., Benvegnù, S., Rueda, C. B., Rábano, A., Satrústegui, J., & Ledesma, M. D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.148 · Cited by 42 · see citing works
MMP‐3 mediates psychosine‐induced globoid cell formation: Implications for leukodystrophy pathology
Ijichi, K., Brown, G. D., Moore, C. S., Lee, J., Winokur, P. N., Pagarigan, R. R., Snyder, E. Y., Bongarzone, E. R., & Crocker, S. J. (2013) · Glia · doi:10.1002/glia.22471 · Cited by 40 · see citing works
Massaro, G., Hughes, M. P., Whaler, S. M., Wallom, K., Priestman, D. A., Platt, F. M., Waddington, S. N., & Rahim, A. A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz317 · Cited by 39 · see citing works
Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins
Saha, P., Shumate, J. L., Caldwell, J. G., Elghobashi‐Meinhardt, N., Lu, A., Zhang, L., Olsson, N., Elias, J. E., & Pfeffer, S. R. (2020) · eLife · doi:10.7554/elife.57089 · Cited by 36 · see citing works
Rocco, M. D., Rossi, A., Parenti, G., Allegri, A. E. M., Filocamo, M., Pessagno, A., Tortori‐Donati, P., Minetti, C., & Biancheri, R. (2005) · Neuropediatrics · doi:10.1055/s-2005-865863 · Cited by 35 · see citing works
Buccinnà, B., Piccinini, M., Prinetti, A., Scandroglio, F., Prioni, S., Valsecchi, M., Votta, B., Grifoni, S., Lupino, E., Ramondetti, C., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05947.x · Cited by 34 · see citing works
Scott‐Hewitt, N., Folts, C. J., Hogestyn, J. M., Piester, G., Mayer-Pröschel, M., & Noble, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx153 · Cited by 32 · see citing works
Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
Thibert, K. A., Raymond, G. V., Tolar, J., Miller, W. P., Orchard, P. J., & Lund, T. C. (2016) · Scientific Reports · doi:10.1038/srep24579 · Cited by 31 · see citing works
Claycomb, K. I., Winokur, P. N., Johnson, K. M., Nicaise, A. M., Giampetruzzi, A., Sacino, A. V., Snyder, E. Y., Barbarese, E., Bongarzone, E. R., & Crocker, S. J. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000117 · Cited by 30 · see citing works
The metabolism of glucocerebrosides — From 1965 to the present
Futerman, A. H., & Platt, F. M. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.11.390 · Cited by 29 · see citing works
KUEMMEL, T. A., Schröeder, R., & Stoffel, W. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199702000-00008 · Cited by 22 · see citing works
Intra- and intercellular trafficking in sphingolipid metabolism in myelination
Wattenberg, B. W. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.11.002 · Cited by 21 · see citing works
Cho, S. M., Vardi, A., Platt, N., & Futerman, A. H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14483 · Cited by 21 · see citing works
Characterization of Inducible Models of Tay-Sachs and Related Disease
Sargeant, T. J., Drage, D., Wang, S., Apostolakis, A. A., Cox, T. M., & Cachón-González, M. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002943 · Cited by 20 · see citing works
Pathological and biochemical studies of fetal Krabbe disease
Ida, H., Rennert, O. M., Watabe, K., Eto, Y., & Maekawa, K. (1994) · Brain and Development · doi:10.1016/0387-7604(94)90013-2 · Cited by 20 · see citing works
Exploring the Therapeutic Landscape of Sphingomyelinases
Shanbhogue, P., & Hannun, Y. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_179 · Cited by 19 · see citing works
Global gene expression in a type 2 Gaucher disease brain.
Myerowitz, R., Mizukami, H., Richardson, K., Finn, L., Tifft, C., & Proia, R. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.06.020 · Cited by 18 · see citing works
Self-citationKyrkanides, S., Brouxhon, S. M., Tallents, R. H., Miller, J. H., Olschowka, J. A., & O’Banion, M. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-186 · Cited by 15 · see citing works
Clinicopathological differences between juvenile and late infantile metachromatic leukodystrophy
Takashima, S., Matsui, A., Fujii, Y., & Nakamura, H. (1981) · Brain and Development · doi:10.1016/s0387-7604(81)80065-4 · Cited by 14 · see citing works
Reddy, A. S., Patel, J. R., Vogler, C. A., Klein, R. S., & Sands, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064647 · Cited by 9 · see citing works
Ceramide and Ganglioside Accumulation in Farber's Lipogranulomatosis.
Prensky, A. L., Ferreira, G., Carr, S., & Moser, H. W. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-126-32554
Flagged first, then by citations
Research works printed but not linked: 3
- [25]Beutler E, Grabowski GA, Gaucher Disease, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, In: The Metabolic and Molecular Bases of Inherited Disease, 2001, pp. 3635– 3668
- [57]Suzuki Y, Oshima A, Nanba E, Beta-galactosidase deficiency (beta-galactosidosis): GM1 gangliosidosis and Morquio B disease, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, In: The Metabolic and Molecular Bases of Inherited Disease., 2001, pp. 3775– 3809.
- [98]Gravel RA, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K, The GM2 gangliosidoses, Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW and Vogelstein B (eds). McGraw-Hill, NY, USA, In: The Metabolic and Molecular Basis of Inherited Disease., 2001, pp. 3827– 3876.
Cited by
Sorted by citations
Lysosomal Functions in Glia Associated with Neurodegeneration
Kreher, C., Favret, J., Maulik, M., & Shin, D. (2021) · Biomolecules · doi:10.3390/biom11030400 · Cited by 38 · see citing works
Lane-Donovan, C., Paredes, M., & Kao, A. W. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102854 · Cited by 3 · see citing works
- Authors
- Allende, M. L., Zhu, H., Kono, M., Hoachlander-Hobby, L. E., Huso, V. L., & Proia, R. L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Proia, Richard L.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 78
- Pages
- 109879
- ISSN
- 0898-6568 (ISSN-L)
- PMC
- PMC7775721
- OpenAlex
- W3111719647
- Cited by
- 37
- References
- 130
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 5
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cellular Signalling (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- sphingolipid degradation, sphingolipidosis, microglia, lysosomal storage disease, neurodegeneration, lysosomal accumulation, myelin, neurodegenerative diseases
- MeSH terms
- Animals, Humans, Mutation, Sphingolipidoses, Sphingolipids, Signal Transduction, Microglia, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review